Heart clinical trials

If you're exploring additional treatment options for a heart condition, you may be interested in an HonorHealth heart clinical trial at the HonorHealth Research Institute.

HonorHealth Research Institute’s clinical trials focus on medical devices and medications that can improve treatment of cardiovascular conditions, including:

  • Atrial fibrillation.
  • Pacemaker/ICD implants
  • Mitral valve replacement for regurgitation (non-surgical)
  • Aortic valve replacement for aortic stenosis (non-surgical)
  • Tricuspid valve replacement for regurgitation (non-surgical)
  • Stents for coronary artery disease
  • Anti-platelet trials

When you participate in a clinical trial, not only are you playing an active role in your own healthcare, you’re also gaining access to innovative investigational devices and drugs before they're available to the general public.

Your clinical trial care team will include:

  • Your cardiologist and your clinical trial research physician.
  • A dedicated research nurse with an extensive background in both research and clinical trials and in cardiovascular disease management.
    • Your nurse is with you at every step of your journey:
      • At your initial appointment.
      • At your side during any medical procedures.
      • Following up with you throughout the trial phase — typically a five-year period.
  • A PhD-level pharmacist.

About cardiovascular research at HonorHealth

Since its launch more than 20 years ago, the HonorHealth Research Institute Cardiovascular Research Program has been driven by a singular passion: to create additional — and groundbreaking — treatment options for patients with cardiovascular disease. In fact, HonorHealth Research Institute's Cardiovascular Research Program is considered a major contributor to the field. An international leader in heart disease research, the program has seen its research findings presented in peer-reviewed journals and at international meetings.

Making major scientific contributions to the treatment of cardiovascular disease, HonorHealth researchers have:

  • Participated as one of 80 international sites for a clinical trial investigating a new leadless pacemaker, Dr. Rahul Doshi implanted the first device in the U.S.
  • Consulted regularly with pharmaceutical and medical device companies on the development of new technologies.
  • Performed clinical trials leading to FDA approvals for medications, including a new form of anticoagulants for patients at risk of developing blood clots.
  • Been involved in multiple structural heart trials to pave the way for non-surgical treatment options for aortic stenosis, mitral and tricuspid valve regurgitation.
  • Participated in new electrophysiology treatment options to manage atrial fibrillation.

Learn more

For more information on HonorHealth Research Institute cardiovascular clinical trials and eligibility, please contact our cardiology research team at 480-323-1046 or email Heartclinicaltrials@HonorHealth.com.